Eccrine miliaria
Salient features
·
Sweat
retention can be caused by obstruction of the eccrine duct at various level
·
Miliaria
crystallina or sudamina (superficial ductal occlusion) – clear vesicles
·
Miliaria
rubra or prickly heat (intermediate ductal occlusion) – erythematous papules or
pustules
·
Miliaria
profunda or mammillaria (deeper ductal occlusion) – white papules
·
Common
in neonates (whose eccrine sweat ducts are not fully developed) and adults
living in hot, humid climates
·
Resolves
with relocation to a cool environment
Introduction
Miliaria is a group
of eccrine disorders that arises due to the occlusion or disruption of eccrine
sweat ducts, resulting in a leakage of sweat into the epidermis (miliaria crystallina
and miliaria rubra) or dermis (miliaria profunda).. Blockage results in
retention of sweat within the duct, causing a sweat retention vesicle to form.
The three forms of miliaria – miliaria
crystallina (sudamina), miliaria rubra (prickly heat) and miliaria profunda –
each reflecting obstruction of sweat ducts at different levels, from the
stratum corneum to the dermal–epidermal junction. In miliaria crystallina, the
obstruction is very superficial, within the stratum corneum, and the vesicle is
subcorneal, containing clear fluid. In miliaria rubra, the obstruction is in
the intraepidermal part of the sweat duct, with leakage and then formation of a
vesicle around the duct. In miliaria profunda, there is rupture of the duct at
the level of or below the dermal–epidermal junction.
Epidemiology
Miliaria is most common in neonates
whose eccrine ducts are not fully developed. It is also common in children and adults
who live or work in very hot, humid environments.
Clinical
features
Each type of miliaria is clinically distinctive.
Miliaria crystallina
Clear, thin‐walled superficial vesicles,
1–2 mm in diameter without an inflammatory areola, are usually symptomless and
develop in crops. It is most commonly observed on the face and upper trunk of
neonates and on the trunk in children and adults. The vesicles soon rupture,
and are followed by superficial, branny desquamation.
Miliaria rubra
The
most common and clinically important form is miliaria rubra. The lesions are uniformly small, non-follicular, erythematous macules
and papules topped by a punctate vesicle,
which may be present in very large numbers. Characteristically, the lesions
produce intense discomfort in the form of an unbearable pricking sensation. Onset is
within days to weeks of exposure to hot environments. Miliaria rubra may
become pustular, especially in chronic, extensive cases. Miliaria pustulosa, as
this variant is known, is sterile, although secondary bacterial infection may
occur. Relief is often instantaneous when
the stimulus to sweating is abolished by a cool shower. Miliaria rubra typically
occurs on the neck and upper trunk in neonates and in both children
and adults in hot climates. Extensive
cases of miliaria rubra can lead to hyperpyrexia.
Miliaria profunda
This nearly always follows repeated
attacks of miliaria rubra when occlusion may extend to a deeper level and produce
miliaria profunda. Because of their deeper location, the sweat retention
vesicles of miliaria profunda appear clinically as multiple discrete, pale, firm1 to 3 mm papules that resemble gooseflesh. They start within minutes of initiation of sweating and
subside within 1 to 2 hours after the sweating ceases.Since the sweat
retention vesicle lies in the upper dermis below the level of the itch
receptors, lesions of miliaria profunda are asymptomatic. Only in those
patients with concomitant miliaria rubra can pruritus or burning develop. Miliaria profunda is relatively rare and typically
occurs on the trunk and proximal extremities in
adults in hot climates.
THREE TYPES OF MILIARIA |
||||
Type |
Location of obstruction |
Cutaneous lesions |
Patient population(s) |
Most common locations |
Crystallina |
Stratum corneum |
Non-pruritic, clear, fragile, 1 mm vesicles |
Neonates <2 weeks of age |
Face and trunk |
Rubra |
Mid-epidermis |
Pruritic, erythematous, 1–3 mm papules; may
have pustules (miliaria pustulosa) |
Neonates 1–3 weeks of age |
Neck and upper trunk |
Profunda |
Dermal–epidermal junction |
Non-pruritic, white, 1–3 mm papules |
Adults in hot climates; often with multiple
bouts of miliaria rubra |
Trunk and proximal extremities |
Disease
course and prognosis
This depends mainly on environmental
factors. If continued sweating occurs, recurrent episodes lasting a few days
are usual, but discomfort may be continuous. However, after a few months some
degree of acclimatization occurs, and the disorder becomes less prevalent.
The most
important complications of miliaria are secondary infection and disturbance of
heat regulation. Secondary bacterial infection may present as impetigo.
Miliaria rubra in young infants may predispose to multiple superimposed
staphylococcal abscesses. When large numbers of sweat glands are occluded and
essentially non-functional, these individuals are at risk for significant
thermoregulatory problems and a compensatory hyperhidrosis of the face is
routinely observed. Axillary and inguinal lymphadenopathy can also be seen,
with resolution upon clearing of the miliaria. The term “tropical anhidrotic
asthenia” has been applied to these patients.
Pathology
Biopsy
specimens demonstrate ductal blockage. Obstruction of sweat ducts at the level
appropriate for each type of miliaria is due to the formation of Keratinous
plugs: in the stratum corneum for miliaria crystallina; the mid-epidermis or
spinous layer for miliaria rubra; and at the dermal–epidermal junction for
miliaria profunda. Sweat retention vesicles may be seen underlying the
respective sites of occlusion. Dermal inflammation is absent in miliaria crystallina,
whereas perivascular lymphocytic infiltrates and vasodilation are evident in
miliaria rubra. An eosinophilic cast can be seen occluding sweat ducts at the
dermal–epidermal junction or intraepidermally in miliaria profunda. Periductal
infiltration of lymphocytes is also seen along with mild focal spongiosis of
the adjacent epidermis. Special stains may reveal Gram-positive bacteria in
both rubra and profunda lesions, but cultures are typically negative unless the
lesions are secondarily infected.
Diagnosis
Each type of
miliaria has such a classic clinical presentation that the diagnosis is usually
apparent.
Treatment
The only really effective prevention
or treatment for all
types of miliaria is avoidance of further
sweating. This can be achieved by placing the patient in a cool environment, in
which sweating stops, for several days to weeks. Gradually, the obstructed
sweat ducts shed their occluding keratinous plugs and normal sweating is
restored. Even if this is achieved only for a
few hours a day, as in an air‐conditioned
office or bedroom, considerable relief is experienced. For the very susceptible
person, a move away from tropical climates may be essential. Avoidance of
excessive clothing, friction from clothing, excessive use of soap and contact
of the skin with irritants will reduce the incidence. The large number of
treatments advocated for prickly heat is the best indication of their relative
ineffectiveness if sweating is not reduced. In the absence of gross secondary
sepsis, the effect of topical or systemic antibiotics or other antibacterial
preparations on established miliaria is disappointing, but they may have some
role in prophylaxis. Oral ascorbic acid 500 mg twice daily is found to diminish
the severity of miliaria, as is the degree of subsequent anhidrosis. Calamine
lotion is probably as effective as anything for the relief of discomfort, but
because of its drying effect, a bland emollient (e.g. oily cream or menthol in
aqueous cream) may subsequently be required to prevent further epidermal
damage.
Therapeutic ladder
First line
·
Control local environment (remove
excess bedding, fans, air conditioning)
·
Cool the skin (damp compresses, cool
showers)
·
Avoid tight or excessive clothing
Second line
·
Menthol (e.g. 0.5% menthol in
aqueous cream)
·
Topical antibiotics if there is
secondary infection
·
Mild topical steroids
Third line
·
Removal to cooler climate
·
Prophylactic oral vitamin C